ES373377A1 - Procedimiento para la obtencion de quinalozinonas. - Google Patents

Procedimiento para la obtencion de quinalozinonas.

Info

Publication number
ES373377A1
ES373377A1 ES373377A ES373377A ES373377A1 ES 373377 A1 ES373377 A1 ES 373377A1 ES 373377 A ES373377 A ES 373377A ES 373377 A ES373377 A ES 373377A ES 373377 A1 ES373377 A1 ES 373377A1
Authority
ES
Spain
Prior art keywords
quinazolinones
aryl
substituted
pharmaceutical agents
quinazolinone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES373377A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES373377A1 publication Critical patent/ES373377A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ES373377A 1968-11-12 1969-11-10 Procedimiento para la obtencion de quinalozinonas. Expired ES373377A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00775201A US3723432A (en) 1968-11-12 1968-11-12 1-substituted-4-aryl-2(1h)-quinazolinones and their preparation

Publications (1)

Publication Number Publication Date
ES373377A1 true ES373377A1 (es) 1972-05-16

Family

ID=25103642

Family Applications (1)

Application Number Title Priority Date Filing Date
ES373377A Expired ES373377A1 (es) 1968-11-12 1969-11-10 Procedimiento para la obtencion de quinalozinonas.

Country Status (19)

Country Link
US (2) US3723432A (es)
AT (4) AT310176B (es)
BE (1) BE741529A (es)
BG (10) BG16042A3 (es)
BR (1) BR6914095D0 (es)
CH (1) CH521972A (es)
DE (1) DE1956384C3 (es)
DK (1) DK129347B (es)
ES (1) ES373377A1 (es)
FR (1) FR2024830B1 (es)
GB (1) GB1282612A (es)
IE (1) IE33933B1 (es)
IL (1) IL33348A (es)
NL (1) NL6916514A (es)
NO (1) NO124032B (es)
OA (1) OA03829A (es)
PL (1) PL72695B1 (es)
SE (2) SE374920B (es)
ZA (1) ZA697910B (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923803A (en) * 1968-07-18 1975-12-02 Sumitomo Chemical Co 2(1H)-Quinozalinones and process therefor
US3642791A (en) * 1969-08-13 1972-02-15 Sandoz Ag Morpholino-1-substituted-2(1h)-quinazolinones
US4208343A (en) * 1970-10-30 1980-06-17 Westinghouse Electric Corp. 2,4 Diamino benzonitrile
BE785937A (fr) * 1971-07-08 1973-01-08 Sandoz Sa Nouveaux derives de la quinazoline, leur preparation et leur application comme medicaments
US3937705A (en) * 1972-03-09 1976-02-10 Sandoz, Inc. 1-isopropyl-7-methyl-4-(p-fluorophenyl)-2(1h)-quinazolinone
US4071516A (en) * 1976-08-20 1978-01-31 Sandoz, Inc. 4-(Acyloxyphenyl)-quinazolin-2(1H)-ones
US4064246A (en) * 1976-10-12 1977-12-20 Sandoz, Inc. Hydroxymethyl-substituted-2(1H)-quinazolinones
US4160092A (en) * 1977-06-16 1979-07-03 E. I. Du Pont De Nemours And Company Quinazolinone oxides and their use as intermediates for pharmaceutical agents
US4224328A (en) * 1979-04-11 1980-09-23 Sandoz, Inc. Methods with 1-substituted-4-aryl-quinazolin-2(1H)-ones and thiones and pyrido[2,3-d]pyrimidin-2-ones as platelet aggregation inhibitors
CH645362A5 (de) * 1979-07-05 1984-09-28 Sandoz Ag Verfahren zur herstellung von 4-phenyl-2(1h)-chinazolinonen.
FR2676042B1 (fr) * 1991-05-02 1993-07-23 Commissariat Energie Atomique Procede de preparation d'un borohydrure de metal alcalin tel que le borohydrure de lithium.
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
AR038658A1 (es) 2001-06-15 2005-01-26 Novartis Ag Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento
WO2003043995A1 (en) * 2001-11-20 2003-05-30 Cytokinetics, Inc. Process for the racemization of chiral quinazolinones
EP1480980A4 (en) * 2002-02-15 2005-04-20 Cytokinetics Inc SYNTHESIS OF QUINAZOLINONES
BR0309892A2 (pt) * 2002-05-09 2011-04-05 Cytokinetics Inc composto, composição, métodos para modular a atividade da cinesina de ksp, para inibir a ksp, e para o tratamento de uma doença proliferativa celular, e, uso de um composto
JP2005530785A (ja) 2002-05-09 2005-10-13 サイトキネティクス・インコーポレーテッド 化合物、組成物、及び方法
US7038048B2 (en) * 2002-05-23 2006-05-02 Cytokinetics, Inc. 3H-pyridopyrimidin-4-one compounds, compositions, and methods of their use
US7041676B2 (en) * 2002-06-14 2006-05-09 Cytokinetics, Inc. Compounds, compositions, and methods
AU2003256805A1 (en) * 2002-07-23 2004-02-09 Cytokinetics, Inc. Compounds compositions and methods
EP1539180A4 (en) * 2002-08-21 2006-08-30 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
JP2006501306A (ja) * 2002-09-30 2006-01-12 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
GB0230015D0 (en) * 2002-12-23 2003-01-29 Novartis Ag Organic compounds
US7439241B2 (en) 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US8410102B2 (en) 2003-05-27 2013-04-02 Galderma Laboratories Inc. Methods and compositions for treating or preventing erythema
JP2007510652A (ja) * 2003-11-03 2007-04-26 サイトキネティクス・インコーポレーテッド ピリミジン−４−オン化合物、組成物、および方法
WO2005046588A2 (en) * 2003-11-07 2005-05-26 Cytokinetics, Inc. Compounds, compositions, and methods
JP2007513154A (ja) * 2003-12-08 2007-05-24 サイトキネティクス・インコーポレーテッド 化合物、組成物及び方法
WO2009002808A2 (en) * 2007-06-22 2008-12-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
US8058469B2 (en) * 2008-11-03 2011-11-15 Sabic Innovative Plastics Ip B.V. Method for making carbamates, ureas and isocyanates
EP2329849B1 (en) 2009-11-18 2015-04-29 Galderma Research & Development Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder
US8394800B2 (en) 2009-11-19 2013-03-12 Galderma Laboratories, L.P. Method for treating psoriasis
WO2011117377A2 (en) 2010-03-26 2011-09-29 Galderma Research & Development Improved methods and compositions for safe and effective treatment of erythema
WO2011117378A2 (en) 2010-03-26 2011-09-29 Galderma Research & Development Improved methods and compositions for safe and effective treatment of telangiectasia
US8053427B1 (en) 2010-10-21 2011-11-08 Galderma R&D SNC Brimonidine gel composition
JP2013540143A (ja) 2010-10-21 2013-10-31 ガルデルマ・ソシエテ・アノニム ブリモニジンゲル組成物及び使用方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3452041A (en) * 1965-05-19 1969-06-24 American Home Prod Hydantoin compounds and methods of preparation

Also Published As

Publication number Publication date
BG15573A3 (bg) 1976-06-26
FR2024830A1 (es) 1970-09-04
BG16188A3 (bg) 1972-07-20
PL72695B1 (en) 1974-08-30
SU366612A3 (es) 1973-01-16
CH521972A (de) 1972-04-30
BG16039A3 (bg) 1972-05-20
AT319949B (de) 1975-01-10
IE33933L (en) 1970-05-12
NL6916514A (es) 1970-05-14
USB313531I5 (es) 1975-01-28
BG16036A3 (bg) 1972-05-20
SE376917B (es) 1975-06-16
US3723432A (en) 1973-03-27
ZA697910B (en) 1971-07-28
SE374920B (es) 1975-03-24
OA03829A (fr) 1971-12-24
BG16038A3 (bg) 1972-05-20
BG16043A3 (bg) 1972-05-20
FR2024830B1 (es) 1973-07-13
IL33348A0 (en) 1970-01-29
BG16042A3 (bg) 1972-05-20
DE1956384C3 (de) 1980-10-09
DE1956384A1 (de) 1970-06-11
BR6914095D0 (pt) 1973-02-13
AT319950B (de) 1975-01-10
DE1956384B2 (de) 1980-02-07
BG16040A3 (bg) 1972-05-20
BG16041A3 (bg) 1972-05-20
US3925548A (en) 1975-12-09
IL33348A (en) 1973-04-30
DK129347C (es) 1975-02-17
GB1282612A (en) 1972-07-19
BE741529A (es) 1970-05-11
IE33933B1 (en) 1974-12-11
AT310176B (de) 1973-09-25
AT310169B (de) 1973-09-25
DK129347B (da) 1974-09-30
NO124032B (es) 1972-02-21
BG16037A3 (bg) 1972-05-20

Similar Documents

Publication Publication Date Title
ES373377A1 (es) Procedimiento para la obtencion de quinalozinonas.
AU471598B2 (en) 2-amidazolin 2-ylamino substituted quinoxaline and quinazolines as antihypertensive agents
SE402283B (sv) Karbazoler med antiinflammatorisk, analgetisk och antireumatisk verkan
PH9276A (en) 3,4-dihydro-2(1h)-quinazolinones
JPS5598103A (en) Novel quinazolinone herbicide
DK130115B (da) Analogifremgangsmåde til fremstilling af 1-substituerede 2(1H)-quinazolinoner.
DK127332B (da) Analogifremgangsmåde til fremstilling af terapeutisk virksomme 1-substituerede 2[1H]-quinazolinoner.
ES366271A1 (es) Un procedimiento para la preparacion de esteroides.
IE35594B1 (en) N-(bicycloamino-alkanoyl)-anilines
CH465724A (de) Anodenplatte und ihre Verwendung
ES343018A1 (es) Procedimiento para la fabricacion de difluoroclorometilari-lureas.
IL36598A0 (en) The use of derivatives of n-aryl-oxazolidine-2,4-diones as fungicides,and certain new compounds of this class
IT962172B (it) Perfezionamento nei procedimenti e dispositivi per la spruzzatura di materiali alla fiamma di plasma
CH468457A (de) Rotlumineszierendes Stoffgemisch und dessen Verwendung
ES366209A1 (es) Metodo de preparacion de un compuesto pesticida.
DK120545B (da) Analogifremgangsmåde til fremstilling af 2-methoxy-4-(N<4>-glutarylsulfanilamido)-quinazolin eller farmaceutisk uskadelige metalsalte deraf.
FR1405935A (fr) Perfectionnement apporté aux panneaux publicitaires plus spécialement utilisables le long des axes routiers
CA700411A (en) Pharmaceutical composition having anti-inflammatory properties
IL39948A0 (en) Pharmaceutical compositions as tranquillizers and regularizing the autonomic nervous system
AU3985164A (en) Quinazoline 3-oxide derivatives
CA831985A (en) 2-methoxy-4-(n4-glutarylsulfanilamido) quinazoline
DK127187B (da) Analogifremgangsmåde til fremstilling af 1-propargyl-4-phenyl-2(1H)-quinazolinoner.
AU463486B2 (en) Substituted uretidine-2, 4-diones and their use as herbicides
CA997359A (en) Substituted uretidine-2,4-diones and their use as herbicides
AU289663B2 (en) 2, 4-DIAMINO-7-CHLOROPYRIDS (2, 3-d) PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS